AMR in Asia: Why New Antibiotics Arrive 3 to 5 Years Late

Asia carries the heaviest burden of drug-resistant infection on the planet and anchors the global antibiotic supply chai...

November 14, 2026 | Saturday | Analysis
Made in New Jersey: What America's Drug Tariff Clock Really Means for Small US Generic Makers

100% Default US tariff on imported patented drugs since 2026 0% Tariff on imported generics until Aug 202...

November 14, 2026 | Saturday | Analysis
FDA Warning Letters 2026: Lessons for India, China and Asia-Pacific Pharma

Between 13 January and 10 November 2026, the US FDA posted 513 warning letters. They reached telehealth start-ups, onlin...

November 13, 2026 | Friday | Regulatory
At AI4Sci, Nobel laureates Fred Ramsdell and Sir Konstantin Novoselov explore healthcare’s next frontier

What will it take to turn fundamental scientific discoveries into the next generation of healthcare innovations? At AI4S...

November 12, 2026 | Thursday | News
Asia Biotech 2026: The Year the Region Set the Terms

On 8 October 2026, a number quietly crossed a line. According to data provider PharmCube, the value of overseas licensin...

November 10, 2026 | Tuesday | Analysis
Korea's IVI supports Minapharm for development of Bundibugyo ebolavirus vaccine

South Korea-based International Vaccine Institute (IVI) has joined Bayer AG and the Coalition for Epidemic Preparedness ...

November 6, 2026 | Friday | News
Birgit Girshick Puts Charles River’s Recovery in Focus as Organic Growth Reaches 4.7%

  --Charles River Laboratories’ third-quarter results offer CEO Birgit Girshick stronger evidence of impro...

November 5, 2026 | Thursday | Company results
Merck KGaA to divest CDMO business to Lonza in mid-triple-digit million-euro deal

Merck, a leading science and technology company, has signed a definitive agreement to divest its contract deve...

November 3, 2026 | Tuesday | News
BIX 2026 Closes: From Brain Signals to Business Signals, Korea's Biotech Agenda Comes Into Focus

BIOPLUS-INTERPHEX KOREA 2026 closed at COEX on Friday with its shortest conference day and, in some ways, its most forwa...

October 30, 2026 | Friday | Analysis
WuXi AppTec Raises 2026 Revenue Outlook to RMB 61.9 Billion as Nine-Month Profit Surges 74.4%

WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), tod...

October 26, 2026 | Monday | Company results
Samsung Biologics raises 2026 growth outlook as quarterly revenue reaches KRW 1.49 trillion

Samsung Biologics reported third-quarter revenue of KRW 1.49 trillion and operating profit of KRW 640 billion, supported...

October 22, 2026 | Thursday | News
EQT to Acquire QIAGEN in Landmark €10.8 Billion Take-Private Deal

QIAGEN and EQT Private Equity agree on an all-cash public takeover offer for all outstanding QIAGEN shares at an off...

October 22, 2026 | Thursday | News
Healthcare’s AI Ambitions Are Colliding With a Data Wall

Healthcare is generating more data than ever, yet much of its potential remains locked within disconnected systems. As a...

October 21, 2026 | Wednesday | News
Merck expands rare disease portfolio with $1.3 billion Silence Therapeutics acquisition

Purchase price of $20 per ADS in cash represents an enterprise value of $1.1 billion and an equity value of approximat...

October 21, 2026 | Wednesday | News
From 200 Antibody Variants to One Winning Candidate: How Sartorius Is Accelerating Biologics Development

Artificial intelligence is reshaping biologics development by enabling faster antibody selection, early identification o...

October 21, 2026 | Wednesday | Opinion
AI drug discovery must deliver repeatable value beyond hype: Insilico Medicine’s Feng Ren

Artificial intelligence is changing how researchers identify therapeutic targets and design molecules, but its lasting v...

October 13, 2026 | Tuesday | Opinion
Independent CGT manufacturers launch global alliance to support therapy scale-up

Cell and gene therapies may now be moving faster than the manufacturing networks built to deliver them. The Alliance of...

October 6, 2026 | Tuesday | News
Qiagen expands AI-powered bioinformatics for research and drug discovery

Qiagen has announced new artificial intelligence (AI) capabilities to help researchers analyse complex biological and ge...

October 7, 2026 | Wednesday | News
Sartorius, MAbSilico join forces to accelerate AI-driven cell line development

Sartorius and France-based MAbSilico have entered a non-exclusive collaboration combining AI-powered predict...

October 2, 2026 | Friday | News
Thermo Fisher advances FTIR microscopy with faster, simplified molecular analysis

Thermo Fisher Scientific has launched the Thermo Scientific™ Nicolet™ RaptIR™ X FTIR Microscope, expan...

September 28, 2026 | Monday | News
APEC’s Opportunity to Lead: Transforming Lung Cancer Outcomes Across Asia Pacific

As Asia Pacific economies grapple with ageing populations, shrinking workforces and rising healthcare expenditure, they ...

September 28, 2026 | Monday | News
Qiagen launches QIAmini to automate small-batch sample preparation

QIAGEN N.V. has announced the launch of QIAmini, a compact automated sample preparation system designed to give research...

September 25, 2026 | Friday | News
Eppendorf introduces new SpinPro® 8 R high-speed centrifuge

Eppendorf is expanding its centrifuge portfolio with the launch of the new SpinPro 8 R, a refrigerated, floor-standing h...

September 23, 2026 | Wednesday | News
J&J reports longest median overall survival with RYBREVANT plus chemotherapy in EGFR exon 20 insertion NSCLC

Johnson & Johnson has reported final overall survival results from the Phase III PAPILLON study evaluating first-lin...

September 15, 2026 | Tuesday | News
Minoryx and Neuraxpharm complete enrolment in Phase III CALYX trial of leriglitazone

Minoryx Therapeutics and Neuraxpharm have completed enrolment in the global Phase III CALYX trial evaluating leriglitazo...

September 10, 2026 | Thursday | News